Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization. (Q38682125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Willem E Fibbe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

29 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

15-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Normal and leukemic stem cell niches: insights and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stromal cells: sensors and switchers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Skeletal muscle-resident MSCs and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stromal cells and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Immunomodulatory effect of mesenchymal stem cells on B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Stem cell transplantation: the lung barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Intravenously Administered Bone Marrow Cells Migrate to Damaged Brain Tissue and Improve Neural Function in Ischemic Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stromal cell 'licensing': a multistep process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Acute graft-versus-host disease following hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Prevention and treatment of acute GvHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Discovery and validation of graft-versus-host disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Mesenchymal stem cells: immune evasive, not immune privileged

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Prospective isolation of human bone marrow stromal cell subsets: A comparative study between Stro-1-, CD146- and CD105-enriched populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Dissecting T cell lineage relationships by cellular barcoding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12984

21 January 2018

Identifiers

DOI

10.1111/NYAS.12984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26713608%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference